Oncology is a perfect fit for the bundled payment model, because it evaluates the outcomes, patient satisfaction, and cost of an oncology episode, said Kim Eason, manager at Horizon Blue Cross Blue Shield of NJ. She said that Horizon adopted the bundled payment model early to cope with New Jersey’s rising healthcare costs.
Oncology is a perfect fit for the bundled payment model, because it evaluates the outcomes, patient satisfaction, and cost of an oncology episode, said Kim Eason, manager at Horizon Blue Cross Blue Shield of NJ. She said that Horizon adopted the bundled payment model early to cope with New Jersey’s rising healthcare costs.
Transcript (slightly modified)
How can episode-based, or bundled, payments improve value and quality in cancer care?
We believe that episode-based payment can improve payments in any type of model, any type of specialty, and oncology care is no different from that. As we look at the shift in changing from fee-for-service to value-based care, oncology fits that model perfectly because it does look at specific services and events that happen to a patient along their care continuum, so we have the opportunity at Horizon to evaluate the total cost of care that patient is receiving within the oncology episode, their outcomes, and then their overall patient satisfaction.
Adoption of bundled payments has so far been fairly slow. Why did Horizon Blue Cross Blue Shield jump in so quickly?
The episode payment model, the reform, it’s really an evolution and not a revolution. So being slow doesn’t surprise us or surprise me, we believe it will take time for those changes to take place. But Horizon knew that inevitably something had to change. New Jersey has the 2nd highest healthcare cost in the nation and we could not continue to just look at cost rising and not figure out ways to address that, and then we decided to build our models around patient satisfaction, quality of care, and then the total cost of care. So that’s the reason why Horizon jumped in, because we knew we wanted to be there as the ground was breaking and not at the end of the event.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More